Zhejiang Garden BiopharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 2/6
Zhejiang Garden BiopharmaceuticalLtd is a dividend paying company with a current yield of 0.49% that is well covered by earnings.
Key information
0.5%
Dividend yield
1.1%
Buyback Yield
Total Shareholder Yield | 1.6% |
Future Dividend Yield | 0.5% |
Dividend Growth | 17.2% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.071 |
Payout ratio | 13% |
Recent dividend and buyback updates
Recent updates
Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Profits May Not Reveal Underlying Issues
Oct 24Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) Has A Somewhat Strained Balance Sheet
Sep 29Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors
Sep 08Why Investors Shouldn't Be Surprised By Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) 27% Share Price Surge
Jun 30Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?
May 31Subdued Growth No Barrier To Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) With Shares Advancing 27%
May 06Why Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300401's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300401's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Zhejiang Garden BiopharmaceuticalLtd Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (300401) | 0.5% |
Market Bottom 25% (CN) | 0.5% |
Market Top 25% (CN) | 2.1% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (300401) (up to 3 years) | 0.5% |
Notable Dividend: 300401's dividend (0.49%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300401's dividend (0.49%) is low compared to the top 25% of dividend payers in the CN market (2.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (13.4%), 300401's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 300401 is paying a dividend but the company has no free cash flows.